Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 JDMF

1 API Suppliers
1 JDMF

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 85815-37-8, Rilmazafone hcl, 25t258x8bv, 450191-s, 5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-n,n-dimethyl-1,2,4-triazole-3-carboxamide;hydrochloride, Unii-25t258x8bv

Molecular Formula

C₂₁H₂₁Cl₃N₆O₃

Molecular Weight

511.8 g/mol

InChI Key

KHINGHZNENOVFD-UHFFFAOYSA-N

FDA UNII

25T258X8BV

1 2D Structure

Rilmazafone Hydrochloride

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-N,N-dimethyl-1,2,4-triazole-3-carboxamide;hydrochloride

2.1.2 InChI

InChI=1S/C21H20Cl2N6O3.ClH/c1-28(2)21(32)20-26-17(11-25-18(30)10-24)29(27-20)16-8-7-12(22)9-14(16)19(31)13-5-3-4-6-15(13)23;/h3-9H,10-11,24H2,1-2H3,(H,25,30);1H

2.1.3 InChI Key

KHINGHZNENOVFD-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CN(C)C(=O)C1=NN(C(=N1)CNC(=O)CN)C2=C(C=C(C=C2)Cl)C(=O)C3=CC=CC=C3Cl.Cl

2.2 Other Identifiers

2.2.1 UNII

25T258X8BV

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 1-(2-(2-chlorobenzoyl)-4-chlorophenyl)-5-glycylaminomethyl-3-dimethylaminocarbonyl-1h-1,2,4-triazole Hydrochloride

2. 450191-s

3. Rilmazafone

4. S 450191

5. S-450191

2.3.2 Depositor-Supplied Synonyms

1. 85815-37-8

2. Rilmazafone Hcl

3. 25t258x8bv

4. 450191-s

5. 5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-n,n-dimethyl-1,2,4-triazole-3-carboxamide;hydrochloride

6. Unii-25t258x8bv

7. Ccris 1929

8. Rilmazafone Hydrochloride [jan]

9. Rilmazafonehydrochloride

10. 450191s

11. Schembl409409

12. Dtxsid80235095

13. Hy-u00228

14. Cs-7384

15. Rilmazafone Hydrochloride [mart.]

16. 1h-1,2,4-triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-n,n-dimethyl-, Monohydrochloride, Dihydrate

17. Rilmazafone Hydrochloride [who-dd]

18. Rilmazafone Hydrochloride Anhydrous

19. Q27253998

20. 5-(((2-aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-n,n-dimethyl-1h-1,2,4-triazole-3-carboxamide Hydrochloride

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₂₁H₂₁Cl₃N₆O₃
Molecular Weight	511.8 g/mol
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	7
Exact Mass	510.074072 g/mol
Monoisotopic Mass	510.074072 g/mol
Topological Polar Surface Area	123 Å²
Heavy Atom Count	33
Formal Charge	0
Complexity	696
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	2